Met Life Investment Management, LLC Care Dx, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 28,900 shares of CDNA stock, worth $611,813. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,900
Previous 30,344
4.76%
Holding current value
$611,813
Previous $471,000
91.51%
% of portfolio
0.01%
Previous 0.0%
Shares
40 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$96 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$66.6 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$63.3 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$43.1 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.13B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...